In: Economics
Explain why provision of health insurance (50 % coinsurance rate) makes demand for health care more price inelastic
This report reviews the health economic research conducted
at
RAND and elsewhere in an effort to summarize what this
research
has to say about the elasticity of demand for health care and to
consider how this set of results applies to the problem of
estimating the
demand for health care that is provided by the Department of
Defense to military members, their families, and retirees.
The work reported here was sponsored by PA&E and was carried
out
jointly by RAND Health’s Center for Military Health Policy
Research
and the Forces and Resources Policy Center of the National
Defense
Research Institute. The latter is a federally funded research and
development center sponsored by the Office of the Secretary
of
Defense, the Joint Staff, the unified commands, and the
defense
agencies.
Understanding the effects of changes in health insurance policies
on
the demand for health care services is an important and timely
topic.
As the Military Health System (MHS) has evolved over time, it
has
begun to adopt cost-containment strategies that have been tested
in
private health plans. These strategies have led to changes in
many
aspects of the health care services offered to Department of
Defense
(DoD) beneficiaries. Each change potentially can affect the
number
of people accessing services, the intensity of use, and the cost to
the
DoD. The goal of this report is to summarize the research
relevant
for considering the effects of policy changes on the demand for
DoD
health care services and associated costs.Although the price
elasticity of demand for medical care in general is
relatively low, certain types of care are found to be somewhat
more
price sensitive. Preventive care and pharmacy benefits are
among
those medical services with larger price elasticities. The finding
that
the demand for preventive care is more price sensitive than the
demand for other types of care is not surprising. The number of
available substitutes for a product is a major determinant of
demand
elasticity. In the case of preventive care, a number of goods and
services could possibly serve as substitutes. As a result, when the
price
of care increases, consumers are able to substitute away from
preventive care toward other goods and services that promote
health
such as nutritional supplements and healthy foods. In addition,
preventive medical services may be seen more as a luxury than
a
necessity and, thus, may be put off when the price of such care
increases. Further, the opportunity cost of obtaining preventive
care is
much higher than it is when the patient is sick, particularly if
the illness keeps the individual out of work. It is also likely,
that since the
benefits of preventive care accrue in the long-term, they are
heavily
discounted. The difference in elasticities may also reflect the
fact
that preventive care and prescription drugs are typically not as
well
covered by insurance. Policymakers in countries around the world
are faced with rising health care costs and are debating ways to
reform health care to reduce expenditures. Estimates of price
elasticity of expenditure are a key component for predicting
expenditures under alternative policies. Using unique
individual-level data compiled from administrative records from the
Chilean private health insurance market, I estimate the price
elasticity of expenditures across a variety of health care
services. I find elasticities that range between zero for the most
acute service (appendectomy) and -2.08 for the most elective
(psychologist visit). Moreover, the results show that at least one
third of the elasticity is explained by the number of visits; the
rest is explained by the intensity of each visit. Finally, I find
that high-income individuals are five times more price sensitive
than low-income individuals and that older individuals are less
price-sensitive than young individuals.Cost sharing in health
insurance schemes is a crucial method that would influence
both health care utilization and financial burden of the insured
population. Effects of
cost sharing of health insurance schemes on demand for medical care
have been
examined in a number of studies. This review is to describe polices
and interventions
of cost sharing in health insurance schemes; and to describe how
the authors have assessed effects of cost sharing methods in health
insurance schemes where available. This review focuses on studies
about methods of cost sharing applied in health insurance schemes.
Health insurance schemes refer to any types of health insurance
including public health insurance and private health insurance,
country-level health insurance and local level health insurance.
Cost sharing methods in this review included co-payment,
coinsurance and deductible. The mixed methods, including co-payment
plus coinsurance, co-payment plus deductible, coinsurance plus
deductible, co-payment plus coinsurance and deductible were also
included in our review.
Studied populations were target population of cost sharing
strategies applied in health insurance schemes. In this review, all
types of study design (methods) except opinion paper, letter, news,
comment, editorial, bibliography, methodological papers, and
resource guides were included. Three types of outcome measures were
used in this review, including use of health services or drugs,
financial risk, and moral hazard. Cost sharing in health insurance
schemes is a crucial method that would influence
both health care utilization and financial burden of the insured
population. The economic purpose of health insurance is to reduce
financial risk of illness for the insured. Facing decreasing prices
of health care paid by the insured, the insured have incentive to
increase their health care utilization due to the price elasticity,
even if some health services are not necessary (moral hazard). In
health insurance schemes,
cost sharing which can take various forms including deductible,
co-insurance or
co-payment, and ceiling implies higher out-of-pocket payment from
the insured for health service. From demand side, the cost sharing
mechanism could prevent users from utilization of health care; from
the insurance designers’ side, the cost sharing could control the
cost of health insurance scheme by correcting the problem of moral
hazard. But too high level of cost sharing may make health
insurance loose the function of financial protection. Hence the
choice about health insurance involves a trade-off between the
gains from risk reduction and losses from the incentive to purchase
more health care when insured (moral hazard)(Manning and Marquis
1996). Many studies examined the existence of moral hazard by
estimating the change of health care demand after change of cost
sharing arrangements (Koc 2005). In Manning’s study (1996), an
estimate of optimal co-insurance rate of 45% was derived using
empirical data at which the marginal gains from increased pooling
equals the marginal loss from increased moral hazard. However, due
to the complexity of health insurance scheme, including the design
of benefit package, premium level, and characteristics of the
insured, optimal demand-side cost sharing level may be difficult to
find.